Innovation ● Inflection ● Impact
The fast track to life-saving discoveries
About i3 Accelerator
The i3 Accelerator (i3A) advances the development of discoveries from Mount Sinai into groundbreaking technologies that aim to help the patient population. The goal of i3A is to increase the pace of commercialization for a promising technology by applying a strategic and milestone-driven investment. Researchers collaborate with MSIP to execute a project strategy to advance technologies beyond the lab bench.
i3A aims to:
How it Works
i3A project candidates are nominated by MSIP’s Business Development (BD) representatives. The BD representatives select technologies with significant commercial potential that have been disclosed to MSIP. After a disclosure is submitted, Principal Investigators (PIs) can work with their BD representative to determine if the technology is a potential fit for i3A.
Are you interested in being considered for i3A and have not disclosed the technology? Disclose here.
After nomination, MSIP will then evaluate if the technology should advance to the proposal review stage. Proposals will be reviewed on a rolling basis. Each proposal will be evaluated by MSIP and an Investment Advisory Committee (IAC) consisting of venture capitalists, entrepreneurs, and members of the pharmaceutical, biotechnology, and/or medical device industries.
Project funding will be awarded following the signing of an Informed Participation Letter (IPL), which will include a finalized project plan and budget. Ongoing funding is contingent on achieving the milestones of the project plan.
Connect with your BD representative
Submit a technology disclosure to MSIP (if not submitted already)
Await nomination by BD representative, if applicable
Develop and submit a full proposal if the nomination is approvedMore information will be provided at that time.
Present the full proposal to the IAC for reviewThe project plan and budget may be revised based on the IAC's feedback.
If awarded, sign the IPL.The IPL must also be signed by MSIP and your Department Administrator.
Execute the project planA program manager from MSIP will work with you to make sure the project moves forward.
In order to be eligible for i3A, the following criteria must be met:
Projects utilizing professional third-party organizations, such as Contract Research Organizations (CROs), is preferred. Eligible technologies that reach the proposal stage will be evaluated by the IAC based on the following criteria:
Questions? Contact us at email@example.com. You may also reach out to Louise Lammers, PhD, Director, Business Development, Emerging Assets at firstname.lastname@example.org or William Chiang, PhD, Business Development Consultant, at email@example.com.